CYBB and COVID-19: To test this hypothesis, NOX2 activation and the regulation of a pro-inflammatory phenotype in EC were studied using an in vitro model of HPMVEC that recreates the “inflammatory load or burden” of the systemic circulation of COVID-19 patients.